Small study hopes to personalize anesthesia for liver transplant patients
NCT ID NCT06909942
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study looked at 3 liver transplant patients to see if muscle loss (sarcopenia) changes how the body responds to the muscle relaxant rocuronium. Researchers measured hand grip strength and used a questionnaire to diagnose sarcopenia before surgery, then tracked how long the drug lasted. The goal was to find if lower doses could be used safely, potentially reducing time spent in the hospital and on a ventilator.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Turgut Ozal Medicine Center Liver Transplantation Institute
Malatya, Battalgazi, 44040, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict stroke recovery?
- Can nerve changes explain Age-Related muscle loss?
- Muscle loss in aging: can diet and exercise turn back the clock?
- Could a simple CT scan reveal which ICU cancer patients are at highest risk?
- Muscle-Saving supplement may shield seniors from Weight-Loss drug side effect
- Can surgery for stomach or esophageal cancer cloud the mind?